On Thursday, Dr. Ross met with the FDA’s Tobacco Products Scientific Advisory Committee (TPSAC) to discuss the importance of smokeless tobacco and other reduced risk nicotine delivery systems to curbing the country’s smoking-related mortality rate. Historically, the FDA has had a hostile stance toward tobacco harm reduction, but Dr. Ross hopes to change that, encouraging them to acknowledge the scientific evidence that shows tobacco harm reduction can help people stop smoking and can save smokers’ lives.
